LIMITED DISCOUNT CODE - ENTER DRAMA15 AT CHECKOUT FOR A 15% DISCOUNT ON YOUR ORDER
“The problem is,” they say, “that there’s not enough information out there – we simply don’t know…” and it is at this point you can cut them off. Rather than there being no research, there is so much of the stuff that it has become impossible to keep on top of it all.
Some people claim the majority of negative vape research comes from just three people: Chapman, Glantz and McKee. This is not true, it conflates opinions being sought or expressed in the public domain with the origin of the research. Chapman is a retired rentamouth, McKee has not authored any study other than the odd paper review-based exercise, and Glantz’ forte is twisting other people’s findings.
Of course, this should surprise nobody seeing as none of them are scientists in any true definition of the term. They are anti-tobacco in the sense that they are puritanically anti tobacco companies, and smokers are simply casualties of the war of words they are waging.
The question that ought to be asked is ‘what is it about their words that they carry a disproportionate weight in the media?’ How come their sound bites take precedent over quality science?
The answer, according to the American Association for Science and Health (ACSH) comes down to snappy, simply headlines. Or rather, scientists conducting proper research looking at aspects of vaping haven’t learnt to write in clear English. The response to that would be, ‘why should they cater to the general public when their papers are aimed at their peers for review?’
ACSH respond: “Whether they like to admit it or not, scientists want to have a broad impact on society. Sure, recognition from other academics is nice, but most scientists would prefer to see their research splashed across the front pages of the New York Times and BBC News.”
Nicola Di Girolamo, in her paper titled "Healthcare articles with simple and declarative titles were more likely to be in the Altmetric Top 100”, discovered that, err, simple headlines get better media coverage.
Researchers looking into vaping need to take note: The media adores a good ecig story, especially if it is gifted to them on a plate with a good press release and easy to understand bullet points.
So, the initial statement can be rewritten: “The problem is,” they say, “that there’s not enough information out there [in the mainstream media] – we simply don’t know…” what we don’t know.
Do you know how many ecig-related papers were published just in the last week of June? All of these:
· “In-person retail marketing claims in tobacco and E-cigarette shops in Southern California” by JS Yang, MM Wood, K Peirce
· “Nicotine delivery to the aerosol of a heat-not-burn tobacco product: comparison with a tobacco cigarette and e-cigarettes” by KE Farsalinos, N Yannovits, T Sarri, V Voudris
· “Electronic Cigarettes as an Introductory Tobacco Product Among Eighth and 11th Grade Tobacco Users—Oregon, 2015” by JZ Hines
· “Why Don't More Smokers Switch to Using E-Cigarettes: The Views of Confirmed Smokers” by N McKeganey, T Dickson
· “Behavioral economic substitutability of e-cigarettes, tobacco cigarettes, and nicotine gum” by MW Johnson, PS Johnson, O Rass, LR Pacek
· “Electronic cigarettes smoking among youth, its trend and factors associated” by S Ali
· “Tobacco Use Among Middle and High School Students—United States, 2011–2016” by A Jamal
· “Electronic Cigarettes in Germany: Patterns of Use and Perceived Health Improvement” by K Lehmann, S Kuhn, J Reimer
· “Advances in Global Health Communication” by CE Beaudoin, T Hong
· “E-vaping device” by SR Rinehart, BS Smith, C Dendy
· “Offsetting the Impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure?” By MA Kaisar, H Villalba, S Prasad, T Liles, AE Sifat
· “Recommended core items to assess e-cigarette use in population-based surveys” by JL Pearson, SC Hitchman, LS Brose, L Bauld
· “Prevalence and correlates of electronic cigarette use among Canadian students: cross-sectional findings from the 2014/15 Canadian Student Tobacco, Alcohol and …” by A Montreuil, M MacDonald, M Asbridge, TC Wild
· “Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013–2014” by BN Coleman, B Rostron, SE Johnson, BK Ambrose
· “The electronic cigarette, do we need to worry?” by ML Løchen
· “Effect of Electronic Cigarette Messages on Young-Adult Behavioral Dispositions Towards Use” by I Ariel
· “Novel method of nicotine quantification in electronic cigarette liquids and aerosols” by M Ogunwale, Y Chen, W Theis, MH Nantz, D Conklin
· “PERCEIVED HEALTH RELATED RISKS OF VAPING AMONG UNDERGRADUATE STUDENTS IN FACULTY OF MEDICINE AND HEALTH SCIENCES, UNIVERSITI …” by HS Minhat, S Selvanathan, A Wahab
· “Attitudes Toward Tobacco 21 Among US Youth” by H Dai
· “Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability” by MF Stiles, LR Campbell, DW Graff, BA Jones, RV Fant
· “Electronic cigarette use as an aid to quit smoking in the representative Italian population PASSI survey” by G Gorini, G Ferrante, E Quarchioni, V Minardi
· “Comparison of Periodontal Parameters and Self-Perceived Oral Symptoms among Cigarette-Smokers, Individuals Vaping Electronic-Cigarettes and Never-Smokers: …” by F Javed, T Abduljabbar, F Vohra, H Malmstrom
· “A study of regulatory policies and relevant issues concerning electronic cigarette use in Taiwan” by TH Jiang, LM Cheng, MA Hawkins
· “CPDD News and Views” by G Kong, S Krishnan-Sarin
· “The impact of cancer drug wastage on economic evaluations” by J Truong, MC Cheung, H Mai, J Letargo, A Chambers
· “Influence of smoking on aneurysm recurrence after endovascular treatment of cerebrovascular aneurysms” by J Futchko, J Starr, D Lau, MR Leach, C Roark
· “Do neurobiological understandings of smoking influence quitting self-efficacy or treatment intentions?” by K Morphett, A Carter, W Hall, J Lucke, B Partridge
· “Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations” by B Fischer, C Russell, P Sabioni, W van den Brink
· “Legal and health dilemmas challenging India's e‐cigarette endorsement” by G Agoramoorthy
· “Global and targeted serum metabolic profiling of colorectal cancer progression” by Y Long, B Sanchez‐Espiridion, M Lin, L White